MARCATILI, MATTEO
MARCATILI, MATTEO
Universita' degli Studi di MILANO
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
2024 G. D'Andrea, M. Pettorruso, G. Di Lorenzo, T.G. Rhee, S. Chiappini, R. Carullo, S. Barlati, R. Zanardi, G. Rosso, M. Di Nicola, I. Andriola, M. Marcatili, M. Clerici, B.M. Dell'Osso, S.L. Sensi, R.B. Mansur, J.D. Rosenblat, G. Martinotti, R.S. Mcintyre
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression
2023 G. Martinotti, B. Dell'Osso, G. Dilorenzo, G. Maina, A. Bertolino, M. Clerici, S. Barlati, G. Rosso, M. Dinicola, M. Marcatili, G. D'Andrea, C. Cavallotto, S. Chiappini, S. Defilippis, G. Nicolo, P. Defazio, I. Andriola, R. Zanardi, D. Nucifora, S. Dimauro, R. Bassetti, M. Pettorruso, R.S. Mcintyre, S.L. Sensi, M. di Giannantonio, A. Vita, G. Baldacci, S. Belletti, A. Bellomo, B. Benatti, M. Carminati, R. Carullo, D. de Berardis, R. de Filippis, R.D. Chiaie, F. di Carlo, G. Di Petta, A. Galluzzo, V. Giorgelli, G. Lombardozzi, V. Martiadis, C. Mattei, A. Mosca, C. Niolu, M. Olivola, M. Percudani, M. Pepe, E. Rossi, M.I. Scardigli, F. Tati, A. Valchera, M. Vismara
Comparing the COVID-19-related PTSD symptoms between psychiatric patients and healthy subjects: an observational retrospective study from Northern Italy
2022 A. Caldiroli, I. Tagliabue, M. Turco, E. Capuzzi, A. Fortunato, A. Tringali, C. Montana, L. Maggioni, C. Pellicioli, M. Sibilla, M. Marcatili, G. Crespi, F. Colmegna, M. Buoli, M. Clerici
Human induced pluripotent stem cells technology in treatment resistant depression : novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
2020 M. Marcatili, C. Sala, A. Dakanalis, F. Colmegna, A. D’Agostino, O. Gambini, B. Dell’Osso, B. Benatti, L. Conti, M. Clerici
Sleep endophenotypes of schizophrenia : slow waves and sleep spindles in unaffected first-degree relatives
2018 A. D'Agostino, A. Castelnovo, S. Cavallotti, C. Casetta, M. Marcatili, O. Gambini, M. Canevini, G. Tononi, B. Riedner, F. Ferrarelli, S. Sarasso
Human induced pluripotent stem cells (hiPSCs) in schizophrenia : Modelling the disease and the treatment response
2017 M. Marcatili, F. Marsoner, A. D’Agostino, S. Scarone, L. Conti
Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia
2016 F. Marsoner, M. Marcatili, T. Karnavas, D. Bottai, A. D'Agostino, S. Scarone, L. Conti
Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia
2016 M. Marcatili, F. Marsoner, A. D’Agostino, T. Karnavas, D. Bottai, S. Scarone, L. Conti
Cellular reprogramming in schizophrenia : from disease modelling to the molecular bases of treatment response
2016 M. Marcatili, F. Marsoner, A. D’Agostino, S. Scarone, L. Conti
Dreaming mentation in healthy people and psychotic patients : a content analysis
2012 A. Castelnovo, R. Ranieri, M. Marcatili, A. D'Agostino, S. Scarone